Ophthalmic Imaging Equipment - Medical Devices Pipeline Assessment, 2019

Table of Contents

• 1.1 List of Tables 5
• 1.2 List of Figures 8

2 Introduction 9

• 2.1 Ophthalmic Imaging Equipment Overview 9

3 Products under Development 10

• 3.1 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 10
• 3.2 Ophthalmic Imaging Equipment - Pipeline Products by Segment 11
• 3.3 Ophthalmic Imaging Equipment - Pipeline Products by Territory 12
• 3.4 Ophthalmic Imaging Equipment - Pipeline Products by Regulatory Path 13
• 3.5 Ophthalmic Imaging Equipment - Pipeline Products by Estimated Approval Date 14
• 3.6 Ophthalmic Imaging Equipment - Ongoing Clinical Trials 15

4 Ophthalmic Imaging Equipment - Pipeline Products under Development by Companies 16

• 4.1 Ophthalmic Imaging Equipment Companies - Pipeline Products by Stage of Development 16
• 4.2 Ophthalmic Imaging Equipment - Pipeline Products by Stage of Development 18

5 Ophthalmic Imaging Equipment Companies and Product Overview 20

• 5.1 ArcScan, Inc. Company Overview 20
  • 5.1.1 ArcScan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 20
• 5.2 Ben-Gurion University of the Negev Company Overview 21
  • 5.2.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 21
• 5.3 Bioinformative Institute of India Company Overview 22
  • 5.3.1 Bioinformative Institute of India Pipeline Products & Ongoing Clinical Trials Overview 22
• 5.4 Brien Holden Vision Institute Company Overview 23
  • 5.4.1 Brien Holden Vision Institute Pipeline Products & Ongoing Clinical Trials Overview 23
• 5.5 Broadspot Imaging Corp Company Overview 24
  • 5.5.1 Broadspot Imaging Corp Pipeline Products & Ongoing Clinical Trials Overview 24
• 5.6 Case Western Reserve University Company Overview 25
  • 5.6.1 Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 25
• 5.7 Columbia University Company Overview 26
  • 5.7.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 26
• 5.8 CW Optics Inc Company Overview 27
  • 5.8.1 CW Optics Inc Pipeline Products & Ongoing Clinical Trials Overview 27
• 5.9 Dalhousie University Company Overview 28
  • 5.9.1 Dalhousie University Pipeline Products & Ongoing Clinical Trials Overview 28
• 5.10 Duke University Company Overview 29
  • 5.10.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview 29
• 5.11 Eye Marker Systems Inc (Inactive) Company Overview 30
  • 5.11.1 Eye Marker Systems Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 30
• 5.12 Eyenuk Inc. Company Overview 31
  • 5.12.1 Eyenuk Inc. Pipeline Products & Ongoing Clinical Trials Overview 31
• 5.13 Fovioptics, Inc. (Inactive) Company Overview 32
  • 5.13.1 Fovioptics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 32
• 5.14 Gemss Co.,Ltd. Company Overview 33
  • 5.14.1 Gemss Co.,Ltd. Pipeline Products & Ongoing Clinical Trials Overview 33
• 5.15 George Washington University Company Overview 34
  • 5.15.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview 34
• 5.16 iHealthScreen Inc Company Overview 35
  • 5.16.1 iHealthScreen Inc Pipeline Products & Ongoing Clinical Trials Overview 35
• 5.17 Kaleyedos Company Overview 36
  • 5.17.1 Kaleyedos Pipeline Products & Ongoing Clinical Trials Overview 36
• 5.18 Massachusetts Eye and Ear Infirmary Company Overview 37
  • 5.18.1 Massachusetts Eye and Ear Infirmary Pipeline Products & Ongoing Clinical Trials Overview 37
• 5.19 National University of Singapore Company Overview 39
  • 5.19.1 National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview 39
• 5.20 NeuroVision Imaging LLC Company Overview 40
  • 5.20.1 NeuroVision Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview 40
• 5.21 Next Dimension Ltd. Company Overview 43
  • 5.21.1 Next Dimension Ltd. Pipeline Products & Ongoing Clinical Trials Overview 43
• 5.22 OcuSciences, Inc. Company Overview 44
  • 5.22.1 OcuSciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
• 5.23 Ocutronics, LLC Company Overview 45
  • 5.23.1 Ocutronics, LLC Pipeline Products & Ongoing Clinical Trials Overview 45
• 5.24 Ohio State University Company Overview 46
  • 5.24.1 Ohio State University Pipeline Products & Ongoing Clinical Trials Overview 46
• 5.25 Optos Plc Company Overview 47
  • 5.25.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview 47
• 5.26 Physical Sciences Inc Company Overview 52
  • 5.26.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 52
• 5.27 Praevium Research Inc. Company Overview 53
  • 5.27.1 Praevium Research Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
• 5.28 Predictek Inc Company Overview 54
  • 5.28.1 Predictek Inc Pipeline Products & Ongoing Clinical Trials Overview 54
• 5.29 Rensselaer Polytechnic Institute Company Overview 55
  • 5.29.1 Rensselaer Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview 55
• 5.30 RetiVue, LLC Company Overview 56
  • 5.30.1 RetiVue, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
• 5.31 Ti-TaMed (PTY) LTD. Company Overview 59
  • 5.31.1 Ti-TaMed (PTY) LTD. Pipeline Products & Ongoing Clinical Trials Overview 59
• 5.32 Tufts University Company Overview 60
  • 5.32.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 60
• 5.33 University College London Company Overview 61
  • 5.33.1 University College London Pipeline Products & Ongoing Clinical Trials Overview 61
• 5.34 University of Arizona Company Overview 62
  • 5.34.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview 62
• 5.35 University of California Los Angeles Company Overview 63
  • 5.35.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 63
• 5.36 University of Colorado Company Overview 64
  • 5.36.1 University of Colorado Pipeline Products & Ongoing Clinical Trials Overview 64
• 5.37 University of South Florida Company Overview 65
  • 5.37.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 65
• 5.38 University of Valencia Company Overview 66
  • 5.38.1 University of Valencia Pipeline Products & Ongoing Clinical Trials Overview 66
• 5.39 Vasoptic Medical, Inc. Company Overview 67
  • 5.39.1 Vasoptic Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
• 5.40 Vision Instruments Pty. Ltd. Company Overview 70
  • 5.40.1 Vision Instruments Pty. Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
• 5.41 VisionQuest Biomedical LLC Company Overview 71
  • 5.41.1 VisionQuest Biomedical LLC Pipeline Products & Ongoing Clinical Trials Overview 71
• 5.42 Visual Pathways, Inc. (Inactive) Company Overview 74
  • 5.42.1 Visual Pathways, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 74

6 Ophthalmic Imaging Equipment- Recent Developments 76

• 6.1 Nov 15, 2019: Vision Source Senior Vice President appointed to the University of Houston System Board of Regents by Texas Governor 76
• 6.2 Nov 12, 2019: ArcScan announces launch of Iclsizing website by London Vision Clinic, Dan Reinstein, MD 76
• 6.3 Nov 07, 2019: Phoenix Technology Group adds enterprise-class security and Windows 10 support to the Phoenix ICON wide-field retinal imaging system 77
• 6.4 Oct 31, 2019: Encouraging additional phase 3 data presented for Abicipar, and start of phase 1 trial for MP0310, the first immuno-oncology DARPin(R) with a novel therapeutic design 78
• 6.5 Oct 31, 2019: Interim management statement - Q3 2019: Encouraging additional phase 3 data presented for Abicipar, and start of phase 1 trial for MP0310, the first immuno-oncology Darpin with a novel therapeutic design 80

7 Appendix 124

• 7.1 Methodology 124
• 7.2 About GlobalData 127
• 7.3 Contact Us 127